AllianceBernstein’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Hold
73,940
﹤0.01% 2803
2025
Q4
$356K Hold
73,940
﹤0.01% 2826
2025
Q3
$374K Hold
73,940
﹤0.01% 2838
2025
Q2
$298K Buy
73,940
+22,470
+44% +$73.1K ﹤0.01% 2915
2025
Q1
$141K Hold
51,470
﹤0.01% 3012
2024
Q4
$219K Sell
51,470
-8,600
-14% -$32.7K ﹤0.01% 3007
2024
Q3
$177K Buy
60,070
+7,490
+14% +$23.8K ﹤0.01% 3059
2024
Q2
$183K Buy
52,580
+40,640
+340% +$136K ﹤0.01% 3050
2024
Q1
$34K Hold
11,940
﹤0.01% 3106
2023
Q4
$42.1K Hold
11,940
﹤0.01% 3142
2023
Q3
$30.9K Hold
11,940
﹤0.01% 3162
2023
Q2
$47K Buy
+11,940
New +$37.9K ﹤0.01% 3134

Other funds holding SRTA

AllianceBernstein's SRTA Position: Q1 2026 in Review

AllianceBernstein held its Strata Critical Medical Inc (SRTA) position steady in Q1 2026 at 73,940 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #2803.

AllianceBernstein first reported a position in SRTA in Q2 2023 and has held it in 12 quarters since. The position peaked at $374K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • AllianceBernstein held 73,940 shares of Strata Critical Medical Inc worth $356K as of Q1 2026.
  • AllianceBernstein left its Strata Critical Medical Inc share count unchanged in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2803 holding.
  • AllianceBernstein first reported a position in Strata Critical Medical Inc in Q2 2023 and has held it in 12 quarters since.
  • AllianceBernstein's Strata Critical Medical Inc position peaked at $374K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.